IsoRay Inc. Reports Operating Results (10-Q)

Author's Avatar
May 16, 2011
IsoRay Inc. (ISR, Financial) filed Quarterly Report for the period ended 2011-03-31.

Isoray Inc. has a market cap of $25.04 million; its shares were traded at around $0.97 with and P/S ratio of 4.74.

Highlight of Business Operations:

Gross profit. Gross profit increased $ 304,940 comparing the three months ended March 31, 2011 to the three months ended March 31, 2010. Gross profit for the three months ended March 31, 2011 increased to $ 357,426 from $ 52,486 in the three months ended March 31, 2010. The increase of 581% is attributed to an increase of sales of $207,478 and a decrease in cost of product sales of $97,462.

Sales and marketing expenses. Sales and marketing expenses were reduced by 47% in the three months ended March 31, 2011 as compared to the three months ended March 31, 2010. The costs were reduced from $ 447,693 in the three months ended March 31, 2010 to $ 235,553 in the three months ended March 31, 2011. The significant reduction of $212,487 is a result of reductions in consulting; marketing and advertising; payroll, benefits and share-based compensation; and travel expenses.

General and administrative expenses. General and administrative expenses did not change materially in the three months ended March 31, 2011 as compared to the three months ended March 31, 2010. General and administrative expenses increased $ 31,369 to $627,593 in the three months ended March 31, 2011 from $596,224 in the three months ended March 31, 2010. The general and administrative expenses have remained stable in this area as there have been no significant changes in the administrative function of the Company during the comparable periods.

Operating loss. The operating loss for the three months ended March 31, 2011 was a significant reduction of $396,957 from $1,090,395 for the three months ended March 31, 2010 compared to $693,438 for the three months ended March 31, 2011. The operating loss reduction of $396,957 or 36% is primarily attributed to the increase in sales, decreased cost of product sales and the recovery of research and development costs through the Internal Revenue Service grants for the three months ended March 31, 2011 when compared to the three months ended March 31, 2010.

Read the The complete Report